Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567264-25-000035
Filing Date
2025-05-06
Accepted
2025-05-06 16:21:05
Documents
3
Period of Report
2025-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1746562857.html 4  
1 FORM 4 wk-form4_1746562857.xml 4 4048
2 EX-24 intensity-formsection16p.htm EX-24 4273
3 intensity-formsection16p001.jpg GRAPHIC 216386
  Complete submission text file 0001567264-25-000035.txt   307972
Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484 203-221-7381
INTENSITY THERAPEUTICS, INC. (Issuer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address
Wesolowski John M (Reporting) CIK: 0001895944 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41109 | Film No.: 25917579